CH492713A - Process for the preparation of esters - Google Patents
Process for the preparation of estersInfo
- Publication number
- CH492713A CH492713A CH342870A CH342870A CH492713A CH 492713 A CH492713 A CH 492713A CH 342870 A CH342870 A CH 342870A CH 342870 A CH342870 A CH 342870A CH 492713 A CH492713 A CH 492713A
- Authority
- CH
- Switzerland
- Prior art keywords
- acid
- carbon atoms
- reaction
- alcohol
- carried out
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 14
- 150000002148 esters Chemical class 0.000 title claims description 6
- -1 alkali metal salt Chemical class 0.000 claims description 15
- 239000002253 acid Substances 0.000 claims description 12
- 125000004432 carbon atom Chemical group C* 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000006243 chemical reaction Methods 0.000 claims description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 239000003960 organic solvent Substances 0.000 claims description 5
- 150000003222 pyridines Chemical class 0.000 claims description 5
- 150000003839 salts Chemical class 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 4
- 229910052739 hydrogen Inorganic materials 0.000 claims description 4
- 239000001257 hydrogen Substances 0.000 claims description 4
- 150000002825 nitriles Chemical class 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 2
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 2
- 230000002378 acidificating effect Effects 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 102220347004 c.89G>A Human genes 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 48
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000000203 mixture Substances 0.000 description 17
- 239000003208 petroleum Substances 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 239000002904 solvent Substances 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 238000009835 boiling Methods 0.000 description 6
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 4
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 125000003854 p-chlorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1Cl 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 238000001953 recrystallisation Methods 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- WGYLIVNGTANQNN-UHFFFAOYSA-N 2-(chloromethyl)-6-(4-chlorophenyl)pyridine hydrochloride Chemical compound Cl.ClCC1=NC(=CC=C1)C1=CC=C(C=C1)Cl WGYLIVNGTANQNN-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 3
- 235000011114 ammonium hydroxide Nutrition 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 230000032050 esterification Effects 0.000 description 3
- 238000005886 esterification reaction Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- DNCXNHXVLMMEBU-UHFFFAOYSA-N 2-(chloromethyl)-6-(4-chlorophenyl)pyridine Chemical compound ClCC1=CC=CC(C=2C=CC(Cl)=CC=2)=N1 DNCXNHXVLMMEBU-UHFFFAOYSA-N 0.000 description 2
- UTUDGPGDJDMICN-UHFFFAOYSA-N 2-[2-(4-chlorophenyl)pyridin-4-yl]acetonitrile Chemical compound C1=CC(Cl)=CC=C1C1=CC(CC#N)=CC=N1 UTUDGPGDJDMICN-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 239000000908 ammonium hydroxide Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000004927 clay Substances 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- IBYUYIGHRRBSQV-UHFFFAOYSA-N 2-(4-chlorophenyl)-6-methyl-1-oxidopyridin-1-ium Chemical compound ClC1=CC=C(C=C1)C1=CC=CC(=[N+]1[O-])C IBYUYIGHRRBSQV-UHFFFAOYSA-N 0.000 description 1
- FDAGFEWXNZJOHU-UHFFFAOYSA-N 2-(4-chlorophenyl)-6-methylpyridine Chemical compound CC1=CC=CC(C=2C=CC(Cl)=CC=2)=N1 FDAGFEWXNZJOHU-UHFFFAOYSA-N 0.000 description 1
- ZRIRCVPXOVMZRG-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)-2-methylpyridin-3-yl]acetic acid Chemical compound C1=C(CC(O)=O)C(C)=NC(C=2C=CC(Cl)=CC=2)=C1 ZRIRCVPXOVMZRG-UHFFFAOYSA-N 0.000 description 1
- FFEUXMNEDHKIQU-UHFFFAOYSA-N 2-[6-(4-chlorophenyl)pyridin-2-yl]acetonitrile Chemical compound ClC1=CC=C(C=C1)C1=CC=CC(=N1)CC#N FFEUXMNEDHKIQU-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical class Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 150000001204 N-oxides Chemical class 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- OIRKOFWRGYABNJ-UHFFFAOYSA-N [6-(4-chlorophenyl)pyridin-2-yl]methanol Chemical compound OCC1=CC=CC(C=2C=CC(Cl)=CC=2)=N1 OIRKOFWRGYABNJ-UHFFFAOYSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- RDHPKYGYEGBMSE-UHFFFAOYSA-N bromoethane Chemical compound CCBr RDHPKYGYEGBMSE-UHFFFAOYSA-N 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical compound C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 150000002367 halogens Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- IOKSBGIYDPJEPY-UHFFFAOYSA-N methyl 2-[6-(4-chlorophenyl)-2-methylpyridin-3-yl]acetate Chemical compound ClC1=CC=C(C=C1)C1=CC=C(C(=N1)C)CC(=O)OC IOKSBGIYDPJEPY-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- GRVDJDISBSALJP-UHFFFAOYSA-N methyloxidanyl Chemical compound [O]C GRVDJDISBSALJP-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/26—Radicals substituted by halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/55—Acids; Esters
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
Description
Verfahren zur Herstellung von Estern Die Erfindung betrifft ein Verfahren zur Herstellung von neuen Estern, die entzündungshemmende, schmerz stillende und antipyretische Eigenschaften haben und die Konzentration von Fibrinogen sowie von Cholesterin und/oder Triglyceriden im Blut herabzusetzen vermögen und somit für die Behandlung oder Prophylaxe von Ko- ronararterienkrankheit und Atherosklerose geeignet sind.
Gemäss der Erfindung werden Ester der Formel I
EMI0001.0005
Das in welcher X Wasserstoff oder einen Alkyl- oder Alkoxy- rest mit höchstens 3 C-Atomen oder ein Halogenatom, Y einen gegebenenfalls durch ein oder zwei Halogenato me substituierten Phenylrest, R1 und R=, die einander gleich oder voneinander verschieden sein können, je Wasserstoff oder einen Alkylrest mit höchstens 3 C-Ato- men und R3 einen Alkylrest mit höchstens 5 C-Atomen bedeuten und die Reste Y und -CR1R2-COOR3 nicht an benachbarte C-Atome des Pyridinkerns gebunden sind, hergestellt.
Zweckmässig kann X z.B. ein Wasserstoffatom, ein Methyl- oder Methoxyradikal oder ein Chlor- oder Brom atom darstellen.
Als Beispiele für das oder die Halogenatome, die gegebenenfalls im Y-Radikal vorhanden sind, kann man Fluor- Chlor- und Bromatome erwähnen. Die Verbin dungen, bei denen das Y-Radikal einen oder zwei Halo- gensubstituenten enthält, stellen bevorzugte Verbindun gen dar, weil sie im allgemeinen aktiver sind, als die entsprechenden unsubstituierten Phenylderivate.
Stellt R1 oder R2 ein Alkylradikal dar, so kann die ses z.B. ein Methylradikal sein. Das Alkylradikal R3 kann z.B. das Methyl- oder Äthylradikal sein. Als Salze der Pyridinderivate sind insbesondere die pharmazeutisch zulässigen Säureadditionssalze, wie z.B. Hydrochloride, Hydrobromide, Sulfate oder Phosphate, geeignet.
erfindungsgemäss Verfahren besteht darin, dass man eine Pyridylalkancarbonsäure der Formel II in welcher X, Y, R1 und R2 die obige Bedeutung be-
EMI0001.0013
sitzen, A eine Carboxyl- oder funktionell abgewandelte Carboxylgruppe bedeutet und die Reste Y und -CR1R2-A nicht an benachbarte C-Atome des Pyridinkerns gebun den sind, mit einem Alkohol der Formel R3OH, in wel cher R3 die obige Bedeutung besitzt, oder einem reak tionsfähigen Derivat davon umsetzt.
Als Pyridylalkancarbonsäure mit funktionell abge wandelter Carboxylgruppe können das entsprechende Ni tril und Alkalimetallsalze eingesetzt werden.
Die Veresterung kann durch Reaktion der Carbon- säure mit dem Alkohol R3OH in Gegenwart einer anor ganischen Säure, z.B. Schwefelsäure, oder von Dicyclo- hexylcarbodiimid durchgeführt werden. Die Reaktion kann gegebenenfalls in einem organischen Lösungsmit tel, z.B. Chloroform, durchgeführt und durch Wärme zufuhr beschleunigt oder zum Abschluss gebracht wer den.
Andererseits kann die Veresterung durch Reak tion der Carbonsäure mit einem dem Alkohol R3OH entsprechenden Diazoalkan, z.B. Diazomethan, in einem organischen Lösungsmittel, z.B. einem Gemisch von Me- thanol und Äther, bewirkt werden. Oder aber die Ver- esterung kann durch Reaktion eines Alkalimetallsalzes der Carbonsäure mit einer Verbindung der Formel R3Hal, wobei R3 ein Alkylradikal mit höchstens 5 C-Atomen darstellt und Hal ein Halogenatom, z.B. ein Chlor- oder Bromatom, darstellt, bewirkt werden. Diese Reaktion kann gegebenenfalls in einem organischen Lösungsmit tel, z.B.
Dimethylformamid, durchgeführt und gegebe nenfalls durch Wärmezufuhr beschleunigt oder zum Abschluss gebracht werden. Die Reaktion des der Car- bonsäure entsprechenden Nitrils mit dem Alkohol er folgt in der Regel unter sauren Bedingungen, z.B. in Gegenwart von Schwefelsäure; sie kann durch Wärme zufuhr beschleunigt oder zum Abschluss gebracht wer den.
Die als Ausgangsprodukte eingesetzten Verbindun gen der Formel II können nach an sich bekannten Me thoden hergestellt werden. Die Erfindung ist im fol genden anhand von Ausführungsbeispielen näher er läutert. <I>Beispiel 1</I> Es wurden 7 g 6-(4-Chlorphenyl)-2-methylpyrid-3-yles- sigsäure in 230 ml Methanol gelöst, und die Lösung wur de langsam zu einer Lösung von 1,1 g Diazomethan in 700 ml Äther zugesetzt, wobei die Lösung auf 5 C wäh rend der Zugabe gehalten wurde.
Die Lösungsmittel wurden unter vermindertem Druck abgedampft, und der feste Rückstand wurde in 100 ml Äther gelöst und die Lösung mit 80 ml einer 5%igen wässerigen Natrium- carbonatlösung und dann mit 80 ml Wasser gewaschen. Die ätherische Lösung wurde an wasserfreiem Natrium sulfat getrocknet, worauf das Lösungsmittel abgedampft wurde. Der Rückstand wurde aus Petroläther (Sdp. 60- 80 C) umkristallisiert. Somit erhielt man Methyl-6-(4- chlorphenyl)-2-methylpyrid-3-ylacetat, Smp. 75-76 C.
<I>Beispiel 2</I> Eine Suspension von 6 g 6-(4-Chlorphenyl)-2-cyano- methylpyridin in 26m1 trockenen Methanols wurde in einem Eisbad auf 0 C gebracht. Dann wurden 17 g kon zentrierter Schwefelsäure langsam hinzugegeben, und die entstehende blassgelbe Lösung wurde 18 Stunden unter Rückfluss erhitzt. Das Reaktionsgemisch wurde zu 150 g Eis zugegeben, und der pH-Wert der Lösung wurde mit einer konzentrierten Ammoniumhydroxydlösung (spez. Gew. 0,88) auf 8 gebracht. Die Lösung wurde 3mal mit 100 ml Äther extrahiert, und von den vereinig ten ätherischen Extrakten wurde das Lösungsmittel ab gedampft. Der feste Rückstand wurde aus Petroläther (Sdp. 60-80 C) umkristallisiert.
Somit erhielt man Me- thyl-6-(4-chlorphenyl)pyrid-2-ylacetat, Smp. 45-46 C.
Die als Ausgangsstoff verwendete Cyanomethylver- bindung wurde wie folgt erzeugt: Eine Lösung von 21 g 6-(4-Chlorphenyl)-2-methylpy- ridin in 400 ml Chloroform wurde in einem Eisbad auf 0 C gebracht. Dann wurden 30,9 g m-Chlorperbenzoe- säure der Lösung langsam, anteilweise zugegeben, und die Lösung wurde 24 Stunden auf 0-4 C gehalten. Die Chloroformlösung wurde mit 150 ml einer 15%igen wäs serigen Kaliumcarbonatlösung geschüttelt, und festes Ka- liumcarbonat wurde hinzugegeben, bis der pH-Wert der wässerigen Schicht auf 9 gebracht wurde.
Die Chlo roformschicht wurde vom Gemisch abgetrennt und dann getrocknet, worauf das Lösungsmittel abgedampft wur de. Somit erhielt man unreines 6-(4-chlorphenyl)-2-me- thylpyridin-N-oxyd. Dieses kann durch Umkristallisie- rung aus Petroläther (Sdp. 60-80 C) gereinigt werden und hat dann einen Schmelzpunkt von 92-94 C.
Es wurden 25 g des unreinen N-Oxyds in 112 ml Acetylchlorid gelöst, und die Mischung wurde 6 Stun den unter Rückfluss erhitzt. Nach Abdampfung des überschüssigen Acetylchlorids wurde der braune ölige Rückstand, der hauptsächlich aus 2-Acetoxymethyl-6- -(4-chlorphenyl)pyridin-hydrochlorid und 2-Chlormethyl- -6-(4-chlorphenyl)pyridin-hydrochlorid bestand, in 350 ml Methanol gelöst. Eine Lösung von 20 g Natriumhydroxyd in 20 g Wasser wurde hinzugegeben, und die Mischung wurde 2 Stunden auf Umgebungstemperatur gehalten. Das Methanol wurde im Vakuum abgedampft und der Rückstand mit Äther und Wasser gemischt. Die ätheri sche Schicht wurde vom Gemisch abgetrennt, und der Äther wurde abgedampft.
Somit erhielt man eine Mi schung aus 6-(4-Chlorphenyl)-2-hydroxymethylpyridin und 2 Chlormethyl-6-(4-chlorphenyl)pyridin, die für die nächste Stufe ausreichend rein war. Zu einer Lösung von 22 g dieser Mischung in 300 ml trockenen Äthy- lendichlorids wurden langsam 11 ml Thionylchlorid zu gegeben, wobei die Temperatur des Reaktionsgemisches nicht über 35-40 C steigen durfte. Die Suspension wurde 1,5 Stunden gerührt und dann filtriert. Somit erhielt man 2 - Chlormethyl- 6 - (4- chlorphenyl)pyridin - hydrochlorid. Durch Umkristallisierung dieses Salzes aus Isopropanol erhielt man die entsprechende Base, Smp. 110-111 C. Es wurden 15 g 2-Chlormethyl-6-(4-chlorphenyl)py- ridinhydrochlorid in 150 ml Wasser gelöst.
Der Lösung wurden 4 g einer konzentrierten Ammoniumhydroxydlö sung (spez. Gew. 0,88) zugesetzt, und die Mischung wur de 3mal mit Chloroform extrahiert. Die vereinigten Chlo roformextrakte wurden getrocknet und das Lösungs mittel wurde abgedampft. Somit erhielt man kristallför- miges 2-Chlormethyl-6-(4-chlorphenyl)-pyridin. Dieser Feststoff wurde in 230 ml trockenen Methanols gelöst, worauf 6,6 g Natriumcyanin hinzugegeben wurden und die Mischung 10 Stunden in einer Stickstoffatmosphäre unter Rückfluss erhitzt wurde. Das Reaktionsgemisch wurde abgekühlt und zur Trockne eingedampft, worauf der Rückstand mit Äther und Wasser gemischt wurde. Die organische Schicht wurde vom Gemisch abgetrennt, und das Lösungsmittel wurde abgedampft.
Der feste Rückstand wurde in 200 ml Äther gelöst und die Lösung durch 250 g neutraler Tonerde (Woelm'sche Korngrösse 1) durchgeleitet. Vom Eluat wurde das Lösungsmittel abgedampft, und der Rückstand wurde aus einem Ge misch aus Äthylacetat und Petroläther (Sdp. 60-80 C) umkristallisiert. Somit erhielt man 6-(4-Chlorphenyl)-2- cyanomethylpyridin, Smp. 80-82 C.
<I>Beispiel 3</I> Eine Lösung von 1,2 g Dimethyl-α-methyl-α-[4-(4- -chlorphenyl)-6-methoxypyrid-2-yl]malonat in 12 ml einer methanolischen 2n-Natriumhydroxydlösung wurde 1 Stun de unter Rückfluss erhitzt und dann in Vakuum einge dampft. Der Rückstand wurde in 12 ml Wasser gelöst. Die klare Lösung wurde mit Eisessigsäure auf einen pH-Wert von 5 gebracht und das Ganze mit Äthylacetat extrahiert. Der Extrakt wurde getrocknet und einge dampft. Der Rückstand wurde mit Petroläther (Sdp. 40- 60 C) schnell trituriert, und die entstehende Mischung wurde filtriert.
Somit erhielt man .a-[4-(4-Chlorphenyl)- -6-methoxypyrid-2-yl]propionsäure, Smp. 84-87 C mit Zers. Eine kleine Probe des bereits beschriebenen Aus gangsproduktes (Säure) wurde mit Diazomethan ver- estert. Somit erhielt man den Methylester, Smp. 65-67 C [nach Umkristallisierung aus Petroläther (Sdp. 40-60 C)]. Beispiel 4 Es wurden 6 g 2-(4-Chlorphenyl)-4-cyanomethylpyri- din in 30 ml Methanol, das 9,3 ml konzentrierter Schwe felsäure enthielt, gelöst und die blassgalbe Lösung wurde 24 Stunden unter Rückfluss erhitzt.
Die Lösung wurde mit 150 g Eis vermengt, und der pH-Wert wurde mit 19 ml einer wässerigen 18n-Ammoniaklösung auf 8 gebracht, worauf der gewünschte Ester durch Extraktion mit Äther isoliert wurde. Das Lösungsmittel wurde abgedampft, und der Rückstand wurde aus Petroläther (Sdp. 40-60 C) umkristallisiert. Somit erhielt man Methyl-2-(4-chlorphe- nyl)pyrid-4-ylacetat, Smp. 48-49 C.
<I>Beispiel 5</I> Es wurden 1,4g 2-(4-Chlorphenyl)-4-(a-cyanoisopro- pyl)-pyridin dadurch hydrolysiert, dass es mit 5n-Salz- säure behandelt wurde. Somit erhielt man a-[2-(4-Chlor- phenyl)pyrid-4-yl]isobuttersäure. Eine Probe dieser Säu re (0,58 g) wurde langsam zu einer gut gerührten Lö sung von überschüssigem Diazomethan in 50 ml Äther während 10 Minuten unter Eiskühlung zugegeben. Nach Aufhören der Stickstoffentwicklung wurde das Lösungs mittel in Vakuum abgedampft.
Somit erhielt man Me- thyl-a-[2-(4-chlorphenyl)pyrid-4-yl]isobutyrat, Smp. 71- 72 C, nach Umkristallisierung aus Petroläther (Sdp. 40- 60 C).
Das als Ausgangsstoff verwendete 2-(4-Chlorphenyl)- -4-(a-cyanoisopropyl)pyridin wurde wie folgt dargestellt: Es wurde 5,7 g 2-(4-Chlorphenyl)-4-cyanomethylpyridin zu einer Natriumamidlösung, die durch Auflösung von 0,595 g Natrium in 240 ml flüssigen Ammoniaks erzeugt wurde, zugegeben, und die Suspension wurde gerührt, bis sich eine klare grüne Lösung ergab. Dann wurden 4,7 ml Methyljodid mit einem Mal hinzugegeben, und die Lö sung wurde 30 Minuten gerührt. Nach Abdampfung des ganzen Ammoniaks wurde der feste Rückstand mit Äther und einer gesättigten wässrigen Natriumchlorid lösung gemischt. Die organische Phase wurde abge trennt, und die wässerige Phase wurde noch 2mal mit Äther extrahiert.
Die zusammengefassten ätherischen Extrakte und die organische Phase wurden eingedampft, wobei sich eine Mischung von Nitrilen (5 g) ergab, die durch Chromatographie auf neutraler Tonerde (Woelm'sche Korngrösse 1; 200 g getrennt wurde. Durch Elution mit Benzol erhielt man eine feste Fraktion (1,7 g), die aus einem Gemisch aus Benzol und Petroläther (Sdp. 60-80 ) umkristallisiert wurde. Somit erhielt man 2-(4- -Chlorphenyl)-4-(a.-cyanoisopropyl)pyridin, Smp. 94 - 96 C.
<I>Beispiel 6</I> Eine Suspension von 1,55 g 6-(4-Chlorphenyl)-2-me- thylpyrid-3-ylessigsäure und 0,498 g Natriumbicarbonat in einem 1:1-Wasser/Methanol-Gemisch (15 ml) wurde kräftig gerührt, bis das Brausen aufgehört hatte und eine klare Lösung erzielt wurde. Die Lösungsmittel wurden unter vermindertem Druck abgedampft, und das Natrium salz wurde durch Zugabe und nachträgliche Abdamp- fung von 25 ml Benzol getrocknet, wobei der letztere Vorgang 3mal wiederholt wurde.
Der wasserfreie weisse Feststoff wurde in 15 ml von wasserfreiem Dimethyl- formamid suspendiert, worauf 1 ml Äthylbromid hin zugegeben wurde und die Mischung 18 Stunden bei Raumtemperatur gerührt wurde. Der klaren Lösung wur- den 75 ml Wasser zugesetzt, und das Ganze wurde 3mal mit je 25 ml eines 1:1-Gemisches aus Äther und Pe troläther (Sdp. 40-60 C) extrahiert. Die zusammengefass- ten organischen Schichten wurden 2mal mit je 25 ml Wasser gewaschen, an Magnesiumsulfat getrocknet und in Vakuum eingedampft.
Somit erhielt man 1,64 g Äthyl- -6-(4-chlorphenyl)-2-methylpyrid-3-ylacetat. Dieses wur de aus Petroläther umkristallisiert (Sdp. 40-60 C) um kristallisiert, wobei sich feine weisse Nadeln mit Smp. 54-55 C ergaben.
Process for the production of esters The invention relates to a process for the production of new esters which have anti-inflammatory, pain-relieving and antipyretic properties and are able to reduce the concentration of fibrinogen and of cholesterol and / or triglycerides in the blood and are therefore suitable for the treatment or prophylaxis of Ko - coronary artery disease and atherosclerosis are suitable.
According to the invention, esters of the formula I
EMI0001.0005
The one in which X is hydrogen or an alkyl or alkoxy radical with a maximum of 3 carbon atoms or a halogen atom, Y is a phenyl radical optionally substituted by one or two halogen atoms, R1 and R =, which can be the same or different from one another, each Hydrogen or an alkyl radical with a maximum of 3 carbon atoms and R3 denotes an alkyl radical with a maximum of 5 carbon atoms and the radicals Y and -CR1R2-COOR3 are not bonded to adjacent carbon atoms of the pyridine nucleus.
Suitably, X can e.g. represent a hydrogen atom, a methyl or methoxy radical or a chlorine or bromine atom.
As examples of the halogen atom or atoms which may be present in the Y radical, fluorine, chlorine and bromine atoms can be mentioned. The compounds in which the Y radical contains one or two halogen substituents are preferred compounds because they are generally more active than the corresponding unsubstituted phenyl derivatives.
If R1 or R2 represents an alkyl radical, this can e.g. be a methyl radical. The alkyl radical R3 can e.g. be the methyl or ethyl radical. As salts of the pyridine derivatives, the pharmaceutically acceptable acid addition salts, such as e.g. Hydrochlorides, hydrobromides, sulfates or phosphates, are suitable.
according to the invention is that a pyridylalkanecarboxylic acid of the formula II in which X, Y, R1 and R2 have the above meaning
EMI0001.0013
sit, A is a carboxyl or functionally modified carboxyl group and the radicals Y and -CR1R2-A are not bound to adjacent carbon atoms of the pyridine nucleus, with an alcohol of the formula R3OH, in which R3 has the above meaning, or one reactive derivative thereof converts.
The corresponding Ni trile and alkali metal salts can be used as the pyridylalkanecarboxylic acid with a functionally modified carboxyl group.
The esterification can be carried out by reacting the carboxylic acid with the alcohol R3OH in the presence of an inorganic acid, e.g. Sulfuric acid, or of dicyclohexylcarbodiimide. The reaction can optionally be carried out in an organic solvent, e.g. Chloroform, carried out and accelerated or brought to completion by the addition of heat.
On the other hand, the esterification can be carried out by the reaction of the carboxylic acid with a diazoalkane corresponding to the alcohol R3OH, e.g. Diazomethane, in an organic solvent, e.g. a mixture of methanol and ether. Or the esterification can be carried out by reacting an alkali metal salt of the carboxylic acid with a compound of the formula R3Hal, where R3 is an alkyl radical with at most 5 carbon atoms and Hal is a halogen atom, e.g. a chlorine or bromine atom. This reaction can optionally be carried out in an organic solvent, e.g.
Dimethylformamide, carried out and, if necessary, accelerated or brought to a conclusion by supplying heat. The reaction of the nitrile corresponding to the carboxylic acid with the alcohol usually takes place under acidic conditions, e.g. in the presence of sulfuric acid; it can be accelerated or completed by adding heat.
The compounds of the formula II used as starting materials can be prepared by methods known per se. The invention is explained in more detail in the fol lowing using exemplary embodiments. <I> Example 1 </I> 7 g of 6- (4-chlorophenyl) -2-methylpyrid-3-ylesetic acid were dissolved in 230 ml of methanol, and the solution was slowly turned into a solution of 1.1 g Diazomethane in 700 ml of ether was added, the solution being kept at 5 C during the addition.
The solvents were evaporated off under reduced pressure and the solid residue was dissolved in 100 ml of ether and the solution was washed with 80 ml of a 5% aqueous sodium carbonate solution and then with 80 ml of water. The ethereal solution was dried over anhydrous sodium sulfate and the solvent was evaporated. The residue was recrystallized from petroleum ether (boiling point 60-80 ° C.). Thus methyl 6- (4-chlorophenyl) -2-methylpyrid-3-ylacetate was obtained, m.p. 75-76C.
<I> Example 2 </I> A suspension of 6 g of 6- (4-chlorophenyl) -2-cyano-methylpyridine in 26 ml of dry methanol was brought to 0 ° C. in an ice bath. Then 17 g of concentrated sulfuric acid was slowly added and the resulting pale yellow solution was refluxed for 18 hours. The reaction mixture was added to 150 g of ice, and the pH of the solution was brought to 8 with a concentrated ammonium hydroxide solution (specific weight 0.88). The solution was extracted 3 times with 100 ml of ether, and the solvent was evaporated from the combined ethereal extracts. The solid residue was recrystallized from petroleum ether (boiling point 60-80 ° C.).
This gave methyl 6- (4-chlorophenyl) pyrid-2-ylacetate, m.p. 45-46 C.
The cyanomethyl compound used as starting material was produced as follows: A solution of 21 g of 6- (4-chlorophenyl) -2-methylpyridine in 400 ml of chloroform was brought to 0 ° C. in an ice bath. Then 30.9 g of m-chloroperbenzoic acid were slowly and partially added to the solution, and the solution was kept at 0-4 ° C. for 24 hours. The chloroform solution was shaken with 150 ml of a 15% aqueous potassium carbonate solution, and solid potassium carbonate was added until the pH of the aqueous layer was brought to 9.
The chloroform layer was separated from the mixture and then dried, whereupon the solvent was evaporated. Thus, impure 6- (4-chlorophenyl) -2-methylpyridine-N-oxide was obtained. This can be purified by recrystallization from petroleum ether (b.p. 60-80 C) and then has a melting point of 92-94 C.
25 g of the impure N-oxide were dissolved in 112 ml of acetyl chloride, and the mixture was refluxed for 6 hours. After evaporation of the excess acetyl chloride, the brown oily residue, which mainly consisted of 2-acetoxymethyl-6- (4-chlorophenyl) pyridine hydrochloride and 2-chloromethyl-6- (4-chlorophenyl) pyridine hydrochloride, was dissolved in 350 ml Dissolved methanol. A solution of 20 g sodium hydroxide in 20 g water was added and the mixture was kept at ambient temperature for 2 hours. The methanol was evaporated in vacuo and the residue mixed with ether and water. The ethereal layer was separated from the mixture and the ether was evaporated.
This gave a mixture of 6- (4-chlorophenyl) -2-hydroxymethylpyridine and 2-chloromethyl-6- (4-chlorophenyl) pyridine, which was sufficiently pure for the next stage. 11 ml of thionyl chloride were slowly added to a solution of 22 g of this mixture in 300 ml of dry ethylene dichloride, the temperature of the reaction mixture not being allowed to rise above 35-40.degree. The suspension was stirred for 1.5 hours and then filtered. Thus 2-chloromethyl-6 - (4-chlorophenyl) pyridine hydrochloride was obtained. Recrystallization of this salt from isopropanol gave the corresponding base, mp 110-111 C. 15 g of 2-chloromethyl-6- (4-chlorophenyl) pyridine hydrochloride were dissolved in 150 ml of water.
4 g of a concentrated ammonium hydroxide solution (specific weight 0.88) were added to the solution, and the mixture was extracted 3 times with chloroform. The combined chloroform extracts were dried and the solvent was evaporated. Thus, crystalline 2-chloromethyl-6- (4-chlorophenyl) pyridine was obtained. This solid was dissolved in 230 ml of dry methanol, whereupon 6.6 g of sodium cyanine was added and the mixture was refluxed for 10 hours in a nitrogen atmosphere. The reaction mixture was cooled and evaporated to dryness, whereupon the residue was mixed with ether and water. The organic layer was separated from the mixture and the solvent was evaporated.
The solid residue was dissolved in 200 ml of ether and the solution was passed through 250 g of neutral clay (Woelm grain size 1). The solvent was evaporated from the eluate, and the residue was recrystallized from a mixture of ethyl acetate and petroleum ether (boiling point 60-80 ° C.). This gave 6- (4-chlorophenyl) -2-cyanomethylpyridine, m.p. 80-82 C.
<I> Example 3 </I> A solution of 1.2 g of dimethyl-α-methyl-α - [4- (4-chlorophenyl) -6-methoxypyrid-2-yl] malonate in 12 ml of a methanolic 2N sodium hydroxide solution was refluxed for 1 hour and then evaporated in vacuo. The residue was dissolved in 12 ml of water. The clear solution was brought to pH 5 with glacial acetic acid and the whole was extracted with ethyl acetate. The extract was dried and evaporated. The residue was quickly triturated with petroleum ether (bp 40-60 ° C.) and the resulting mixture was filtered.
This gave .a- [4- (4-chlorophenyl) - -6-methoxypyrid-2-yl] propionic acid, m.p. 84-87 ° C. with dec. A small sample of the starting product (acid) already described was esterified with diazomethane. The methyl ester was thus obtained, mp 65-67 ° C. [after recrystallization from petroleum ether (boiling point 40-60 ° C.)]. Example 4 6 g of 2- (4-chlorophenyl) -4-cyanomethylpyridine were dissolved in 30 ml of methanol containing 9.3 ml of concentrated sulfuric acid, and the pale yellow solution was refluxed for 24 hours.
The solution was mixed with 150 g of ice and the pH was brought to 8 with 19 ml of an aqueous 18N ammonia solution, whereupon the desired ester was isolated by extraction with ether. The solvent was evaporated and the residue was recrystallized from petroleum ether (bp 40-60 ° C.). This gave methyl 2- (4-chlorophenyl) pyrid-4-ylacetate, m.p. 48-49 C.
<I> Example 5 </I> 1.4 g of 2- (4-chlorophenyl) -4- (a-cyanoisopropyl) pyridine were hydrolyzed by treating it with 5N hydrochloric acid. Thus, a- [2- (4-chlorophenyl) pyrid-4-yl] isobutyric acid was obtained. A sample of this acid (0.58 g) was slowly added to a well-stirred solution of excess diazomethane in 50 ml of ether over 10 minutes while cooling with ice. After the evolution of nitrogen had ceased, the solvent was evaporated off in vacuo.
This gave methyl a- [2- (4-chlorophenyl) pyrid-4-yl] isobutyrate, mp 71-72 ° C., after recrystallization from petroleum ether (boiling point 40-60 ° C.).
The 2- (4-chlorophenyl) -4- (a-cyanoisopropyl) pyridine used as starting material was prepared as follows: 5.7 g of 2- (4-chlorophenyl) -4-cyanomethylpyridine were added to a sodium amide solution which, by dissolution of 0.595 g of sodium in 240 ml of liquid ammonia was added and the suspension was stirred until a clear green solution resulted. Then 4.7 ml of methyl iodide was added all at once and the solution was stirred for 30 minutes. After all the ammonia had evaporated, the solid residue was mixed with ether and a saturated aqueous sodium chloride solution. The organic phase was separated off, and the aqueous phase was extracted twice with ether.
The combined ethereal extracts and the organic phase were evaporated to give a mixture of nitriles (5 g) which was separated by chromatography on neutral clay (Woelm grain size 1; 200 g. A solid fraction was obtained by elution with benzene (1.7 g) which was recrystallized from a mixture of benzene and petroleum ether (b.p. 60-80) to give 2- (4- chlorophenyl) -4- (a.-cyanoisopropyl) pyridine, m.p. 94 - 96 C.
<I> Example 6 </I> A suspension of 1.55 g 6- (4-chlorophenyl) -2-methylpyrid-3-ylacetic acid and 0.498 g sodium bicarbonate in a 1: 1 water / methanol mixture (15 ml) was stirred vigorously until the effervescence had stopped and a clear solution was obtained. The solvents were evaporated off under reduced pressure, and the sodium salt was dried by adding and subsequent evaporation of 25 ml of benzene, the latter process being repeated 3 times.
The anhydrous white solid was suspended in 15 ml of anhydrous dimethylformamide, whereupon 1 ml of ethyl bromide was added and the mixture was stirred at room temperature for 18 hours. 75 ml of water were added to the clear solution, and the whole thing was extracted 3 times with 25 ml each of a 1: 1 mixture of ether and petroleum ether (bp 40-60 ° C.). The combined organic layers were washed twice with 25 ml of water each time, dried over magnesium sulfate and evaporated in vacuo.
Thus 1.64 g of ethyl 6- (4-chlorophenyl) -2-methylpyrid-3-ylacetate were obtained. This was recrystallized from petroleum ether (boiling point 40-60 ° C.) to crystallize, with fine white needles with melting point 54-55 ° C.
Claims (1)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB54135/66A GB1147068A (en) | 1966-12-02 | 1966-12-02 | Phenyl-pyridine derivatives |
| CH1696967A CH492712A (en) | 1966-12-02 | 1967-12-01 | Process for the preparation of pyridine derivatives |
| US6140670A | 1970-08-05 | 1970-08-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH492713A true CH492713A (en) | 1970-06-30 |
Family
ID=27177545
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH342870A CH492713A (en) | 1966-12-02 | 1967-12-01 | Process for the preparation of esters |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH492713A (en) |
-
1967
- 1967-12-01 CH CH342870A patent/CH492713A/en not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD139844A5 (en) | METHOD FOR PRODUCING AN AZYLANILIDE | |
| CH645625A5 (en) | BENZOESAEUR DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS. | |
| EP0039844A2 (en) | Process for the preparation of O-substituted derivatives of (+)-cyanidan-3-ols | |
| DE2655009C2 (en) | ||
| DE3850240T2 (en) | Process for the preparation of O-carboxyarylimidazolinones. | |
| DE2454619A1 (en) | PROCESS FOR PRODUCING NEW HETEROCYCLIC COMPOUNDS | |
| CH492713A (en) | Process for the preparation of esters | |
| DE1468890B1 (en) | Process for the production of tetrahydroindane intermediates for steroid derivatives | |
| AT202152B (en) | Process for the preparation of new dimethylaminopropylidene thiaxanthenes. | |
| DE2525962A1 (en) | NEW HETEROCYCLIC COMPOUNDS, THEIR PRODUCTION AND USE | |
| DE4001002A1 (en) | PYRIDINE-2,4-AND 2,5-DICARBONSAEUREDI (NITROXYALKYL) AMIDES, METHOD FOR THE PRODUCTION AND USE THEREOF | |
| DE69018619T2 (en) | ALPHA, BETA-UNSATURATED KETONES AND KETOXIME DERIVATIVE. | |
| DE2021747A1 (en) | Process for the preparation of new heterocyclic compounds | |
| AT278787B (en) | PROCESS FOR THE PRODUCTION OF NEW CARBONIC ACIDS AND THEIR SALTS | |
| AT215998B (en) | Process for the preparation of new hydrazine derivatives | |
| DE1493567C3 (en) | Esters of alpha-alkylthyroxine derivatives and process for their preparation | |
| AT364836B (en) | METHOD FOR PRODUCING NEW O-SUBSTITUTED DERIVATIVES OF (+) - CYANIDAN-3-OLS AND THE SALTS THEREOF | |
| DE1801312C (en) | 2 (4 biphenylyloxy) -heptanoic acid, its alkali and alkaline earth salts and these compounds fertilize the medicinal products they contain | |
| CH251023A (en) | Process for the preparation of B-picolyl nicotinate. | |
| DE931471C (en) | Process for the production of new esters of the pyridine and piperidine series | |
| DE2528070A1 (en) | 9-THIA-, 9-OXOTHIA- AND 9-DIOXOTHIA- 11,12-SECOPROSTAGLANDINE | |
| CH359703A (en) | Process for the production of new piperidines | |
| DE1470080A1 (en) | 1-Lower-alkyl-5-nitroimidazole-2-carboxamides, a process for their preparation and their use as medicinal products | |
| DE2320377A1 (en) | NEW 1-ACYL HOMOPYRIMIDAZOLE DERIVATIVES AND PROCESS FOR THEIR PRODUCTION | |
| CH501009A (en) | 1-(5-nitro-2-thiazolyl)-2-oxo-imidazolidines - prepn |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PL | Patent ceased |